在子宫内膜异位症治疗中使用Dienogest:叙事文献综述
Joowon Lee1, Hyeon Ji Park1, Kyong Wook Yi1
1Department of Obstetrics and Gynecology, Korea University College of Medicine, Seoul, Republic of Korea.
Clinical and experimental reproductive medicine
|November 23, 2023
概括
迪恩诺杰斯特有效治疗子宫内膜异位症相关的疼痛,并减少病变的复发. 本综述审查了其长期临床疗效,安全性和耐受性,用于管理这种流行生殖年龄疾病.
科学领域:
- 生殖医学 生殖医学
- 妇科 妇科医生 妇科
- 药理学 药理学是指药理学的学科.
背景情况:
- 子宫内膜异位症是一种常见的,依赖于荷尔蒙的疾病,影响生殖年龄的女性,其特点是子宫内膜细胞植入子宫外.
- 症状如经期不良,盆腔疼痛和不孕症显著降低了生活质量.
- 医疗治疗对于缓解疼痛和抑制病变生长至关重要,通常用于术后或经验.
研究的目的:
- 审查dienogest在治疗子宫内膜异位症中的临床疗效.
- 评估dienogest的安全性和耐受性.
- 介绍关于长期使用dienogest治疗子宫内膜异位症的最新发现.
主要方法:
- 对治疗子宫内膜异位症的丁诺日斯特的临床研究进行系统审查.
- 对疼痛管理,症状预防和病变复发的数据进行分析.
- 从长期使用研究中评估安全性和耐受性数据.
主要成果:
- 迪恩诺杰斯特在治疗子宫内膜异位症相关疼痛方面表现出显著的疗效.
- 证据支持dienogest在预防症状复发和减少病变生长方面的作用.
- 这种药物在长期使用时显示出良好的安全性和耐受性.
结论:
- 迪恩诺杰斯特是治疗子宫内膜异位症的有效治疗选择.
- 它在缓解疼痛和治疗病变方面的有效性支持其在临床实践中的应用.
- 持续的研究和长期数据强化了dienogest在子宫内膜异位症治疗中的价值.
相关概念视频
02:07Oogenesis
63.8K
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
63.8K
01:17Drugs for Treatment of Diarrhea-Predominant IBS
183
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
183
01:27Ovarian Cycle
1.3K
The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle...
1.3K
01:22Hormonal Regulation of the Menstrual Cycle
405
The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
405